Michael David Smith, Senior VP, Development at KalVista Pharmaceuticals, Inc. (KALV), sold 7,500 shares at $26.83 ($201K) on 2021-06-01, disclosed to the SEC on 2021-06-03.
Open-market sale of $201k KALV by Senior VP, Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.